Advances in stem cell transplantation: making it better and safer. Review uri icon

Overview

abstract

  • The development of reduced-intensity regimens has allowed physicians and patients to explore this option even in older patients. Current results underscore that age by itself should no longer be a contraindication for allogeneic transplantation in these patients, and long-term disease control with good quality of life is possible. Future trials combining novel antileukemic therapies and novel transplantation technologies are being explored. These trials should allow more patients with acute myeloid leukemia or myelodysplastic syndromes to achieve long and productive lives.

publication date

  • January 1, 2009

Research

keywords

  • Leukemia, Myeloid, Acute
  • Medical Oncology
  • Myelodysplastic Syndromes
  • Stem Cell Transplantation

Identity

Scopus Document Identifier

  • 74049138748

Digital Object Identifier (DOI)

  • 10.3816/CLM.2009.s.026

PubMed ID

  • 19778855

Additional Document Info

volume

  • 9 Suppl 3